Cantor Fitzgerald Upgrades Seattle Genetics (SGEN) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/4/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Cowen Starts Seattle Genetics (SGEN) at Market Perform
November 4, 2014 7:27 AM ESTCowen initiated coverage on Seattle Genetics (NASDAQ: SGEN) with a Market Perform rating.
For an analyst ratings summary and ratings history on Seattle Genetics click here. For more ratings news on Seattle Genetics click here.
Shares of Seattle Genetics closed at $37.25 yesterday.
... MoreSeattle Genetics (SGEN) Tops Q3 EPS by 11c
October 30, 2014 5:08 PM EDTSeattle Genetics (NASDAQ: SGEN) reported Q3 EPS of ($0.13), $0.11 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $75.8 million versus the consensus estimate of $66.9 million.
For earnings history and earnings-related data on Seattle Genetics (SGEN) click here.
... More